CA
NZ
UK
AU
IND
US
…
TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis-infused artisan edibles. It also operates retail dispensaries under the Apothecarium brand name in California, Pennsylvania, and New Jersey. In addition, the company owns various synergistic businesses under Gage Growth, Pinnacle, TerrAscend NJ, Ilera Healthcare, HMS Health and HMS Processing, Valhalla Confections, State Flower, Arise Bioscience Inc., and TerrAscend Canada brands. It serves medical and legal adult-use markets. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
TerrAscend Corp. is a vertically integrated cannabis company operating cultivation, manufacturing and retail businesses in licensed U.S. and Canadian markets. Major long-term growth drivers include expansion of legalized adult-use markets, scaling retail and wholesale distribution, and product development; its vertical integration and regulated-market presence may support market-share gains as demand grows.
Material risks include ongoing U.S. federal prohibition and regulatory uncertainty, intense sector competition, capital and liquidity pressures, and execution risk tied to scaling operations, and investors should monitor regulatory developments and balance-sheet metrics.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -310.19M | 34.45M | -99.18M | -166.37M |
| Minority interest | 4.56M | -3.02M | -0.61M | 2.42M |
| Net income | -303.96M | 3.11M | -121.65M | -165.19M |
| Selling general administrative | 106.15M | 80.97M | 58.95M | 47.22M |
| Gross profit | 101.50M | 112.10M | 113.86M | 6.38M |
| Reconciled depreciation | 24.60M | 16.64M | 13.00M | 5.60M |
| Ebit | -20.97M | 35.33M | 20.68M | -44.31M |
| Ebitda | -246.52M | 77.14M | 59.82M | -39.99M |
| Operating income | -14.30M | 23.48M | 46.82M | -45.59M |
| Other operating expenses | - | - | - | 0.72M |
| Interest expense | 39.06M | 26.06M | 11.05M | 4.34M |
| Tax provision | 10.78M | 28.31M | 21.86M | 1.24M |
| Net interest income | -39.06M | -26.06M | -11.05M | -4.34M |
| Income tax expense | -10.78M | 28.88M | 10.77M | 1.77M |
| Total revenue | 247.83M | 210.42M | 155.52M | 64.97M |
| Total operating expenses | 262.13M | 186.94M | 108.70M | 110.56M |
| Cost of revenue | 146.32M | 98.31M | 41.66M | 58.59M |
| Total other income expense net | -256.82M | 37.03M | -134.95M | -116.44M |
| Discontinued operations | -25.95M | -9.52M | -14.63M | -14.63M |
| Net income from continuing ops | -320.97M | 6.13M | -121.04M | -167.62M |
| Net income applicable to common shares | -329.91M | 3.11M | -139.20M | -160.67M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 701.59M | 581.93M | 473.57M | 352.73M |
| Intangible assets | 239.70M | 168.98M | 120.85M | 111.29M |
| Other current assets | 18.52M | 39.23M | 5.16M | 5.48M |
| Total liab | 380.42M | 352.98M | 464.85M | 295.07M |
| Total stockholder equity | 318.80M | 223.59M | 0.93M | 51.05M |
| Other current liab | 42.10M | 28.75M | 59.34M | 41.30M |
| Capital stock | 0.00M | 535.42M | 251.95M | 198.96M |
| Retained earnings | -618.26M | -314.65M | -318.59M | -182.56M |
| Other liab | 47.20M | 84.88M | 146.78M | 145.54M |
| Good will | 90.33M | 90.33M | 78.83M | 73.32M |
| Other assets | 4.30M | 9.08M | 13.34M | 11.51M |
| Cash | 26.16M | 79.64M | 59.14M | 9.11M |
| Total current liabilities | 137.91M | 66.19M | 93.48M | 109.83M |
| Net debt | 168.03M | 105.50M | 129.20M | 54.61M |
| Short long term debt | 48.34M | 8.84M | 5.72M | 48.28M |
| Other stockholder equity | 2.08M | 2.82M | -3.66M | -0.79M |
| Property plant equipment | 245.26M | 141.61M | 133.47M | 87.78M |
| Total current assets | 121.99M | 172.49M | 95.55M | 64.82M |
| Long term investments | - | - | 1.38M | 0.99M |
| Net tangible assets | -11.23M | -35.16M | -200.62M | -131.72M |
| Short term investments | 3.60M | - | - | 0.36M |
| Net receivables | 22.44M | 12.49M | 10.86M | 34.94M |
| Long term debt | 145.85M | 176.31M | 182.61M | 15.44M |
| Inventory | 46.34M | 36.09M | 20.56M | 15.53M |
| Accounts payable | 44.29M | 27.92M | 27.38M | 19.40M |
| Non currrent assets other | 3.46M | 5.11M | 3.92M | - |
| Non current assets total | 579.59M | 438.71M | 345.99M | 283.27M |
| Capital lease obligations | 40.64M | 31.95M | 24.28M | 15.87M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -27.58M | -49.53M | 0.15M | 1.81M |
| Change to liabilities | -11.68M | 3.29M | 7.43M | 2.45M |
| Total cashflows from investing activities | -27.58M | -132.42M | -45.89M | -104.22M |
| Net borrowings | 0.07M | -3.73M | 147.46M | 58.18M |
| Total cash from financing activities | 3.72M | 182.20M | 133.41M | 136.93M |
| Change to operating activities | -6.43M | -10.68M | -59.95M | -1.50M |
| Net income | -329.91M | 3.11M | -139.20M | -160.67M |
| Change in cash | -52.88M | 20.42M | 50.06M | -6.80M |
| Begin period cash flow | 79.64M | 59.23M | 9.33M | 16.67M |
| End period cash flow | 26.76M | 79.64M | 59.14M | 9.11M |
| Total cash from operating activities | -26.12M | -31.82M | -36.97M | -39.84M |
| Issuance of capital stock | 0.00M | 173.48M | 74.98M | 51.01M |
| Depreciation | 24.60M | 13.86M | 12.52M | 5.53M |
| Other cashflows from investing activities | -0.09M | -0.62M | -0.89M | -4.34M |
| Change to inventory | 0.68M | -18.51M | -8.09M | -6.65M |
| Change to account receivables | 2.86M | -3.21M | -4.04M | 0.20M |
| Other cashflows from financing activities | -20.70M | -18.33M | -92.36M | 1.91M |
| Change to netincome | 279.15M | -12.74M | 143.00M | 118.15M |
| Capital expenditures | 39.63M | 39.84M | 43.78M | 32.83M |
| Change in working capital | 0.03M | -36.80M | -11.57M | -5.22M |
| Stock based compensation | 12.16M | 14.94M | 13.00M | 9.82M |
| Other non cash items | 3.21M | 15.73M | 1.53M | 49.61M |
| Free cash flow | -68.02M | -72.66M | -22.03M | -71.18M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| TSNDF TerrAscend Corp. |
-0.02 5.53% |
0.42 | - | - | - | - |
| MKKGY Merck KGaA ADR |
-0.74 2.19% |
33.06 | 21.25 | 14.93 | 3.10 | 2.14 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
170.05 | 24.86 | 15.11 | 3.13 | 1.98 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.34 1.66% |
21.18 | - | 10.96 | 0.01 | 1.20 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
41.72 | - | 10.66 | 0.01 | 1.16 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...